Featured Videos

After spending three terrific days in Boston, covering the BPI meeting, the GEN team is heading back home. Right before catching his train, John Sterling, Editor-in-Chief at GEN, joined Julianna LeMieux, PhD, Deputy Editor-in-Chief, and Kevin Davies, PhD, GEN‘s Editor at Large, to share their impressions of what they had learned over the past few days.

Bioprocessing in Beantown: GEN Reports Live from Day 2 at BPI

John Sterling, GEN‘s Editor-in-Chief, has been attending the Bioprocess International meeting since its inception. In contrast, Julianna LeMieux, PhD, Deputy Editor-in-Chief, attended the meeting for the first time this year. The two sat down with Kevin Davies, PhD,  to talk about the first day of the meeting, the sessions they attended, and the trends that they are noticing.

Boston and Bioprocessing: GEN Reports Live from the First Day at BPI

GEN September 2023 issue cover

It’s September, that time of year when back-to-school feelings come over us whether we’re enrolled in school or not. In keeping with those feelings, GEN is posting a course selection guide, or what we’re normally inclined to call a table of contents. And, yes, there’s a lot of required reading: epigenome editing, nonviral gene therapy delivery systems, liquid biopsies, noncanonical amino acids, and cryogenic electron microscopy. You can take a recess whenever you like, but don’t miss the pep rally, our listing of the top 10 biopharma clusters. It may seem retrospective. But it actually asks us to consider how the interregional competition to accommodate life sciences companies will play out, given current trends in NIH funding, VC funding, patents, laboratory space, and employment. Whichever region you’re in, stay full of that old school spirit. And pick up some extra credit by reading editorials on digital biomanufacturing, bioinformatics challenges, and chemotherapy shortages.